We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Adams Plc | LSE:ADA | London | Ordinary Share | IM00B986V543 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.50 | 5.00 | 8.00 | 6.50 | 6.50 | 6.50 | 0.00 | 08:00:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | -2.19M | -2.37M | -0.0162 | -4.01 | 9.48M |
TIDMADA
RNS Number : 5188S
Adams PLC
26 June 2018
26 June 2018
Adams Plc
("Adams" or the "Company")
Annual Report and Financial Statements 2018
AUDITED RESULTS FOR THE YEARED 31 MARCH 2018
Adams Plc ("Adams" or the "Company) announces its audited financial results for the year ended 31 March 2018.
Highlights:
- Net assets at 31 March 2018 of GBP2.11 million (2017: GBP0.95 million).
Net assets per share 2.55 pence at 31 March 2018 (2017: 2.29 pence).
- Profit after tax of GBP0.02 million (2017: profit of GBP0.01 million). - Net proceeds of GBP0.98 million from new share subscriptions. - Investments at 31 March 2018 valued at GBP2.07 million (2017: GBP0.94 million). - Spend on new investments of GBP1.59 million (2017: GBP0.02 million). - Investment realisation proceeds of GBP0.73 million (2017: GBP0.15 million). - Change in presentational currency from Euros to Pounds Sterling. - Adoption of revised investing policy.
Michael Bretherton, Chairman, said:
"The Board continues to seek attractive investment opportunities coupled with a focus on financial discipline as the strategy to best navigate challenging markets and the uncertain global climate. We remain committed to delivering additional value for our shareholders going forward."
The Company's Annual Report 2018 will shortly be posted to shareholders together with a Circular and Notice of Annual General Meeting, copies of which will be made available on the Company's website at www.adamsplc.co.uk under the Investor Relations / Company & Shareholder Documents section. The Annual General Meeting is to be held at 11.00 a.m. on Friday 10 August 2018 at IOMA House, Hope Street, Douglas, Isle of Man, IM1 1AP.
Enquiries:
Adams plc Michael Bretherton Tel: +44 1534 719 761
Nomad Cairn Financial Advisers LLP. Sandy Jamieson, James Caithie Tel: +44 207 213 0880
Broker Peterhouse Capital Limited. Heena Karani Tel: +44 207 469 3393
Chairman's Statement
Adams Plc (the "Company") is an AIM listed investment company primarily focused on special situation investment opportunities in the small to middle-market capitalisation sectors in the UK or Europe.
The presentational currency of Adams Plc ("Adams" or the "Company") was changed during the year from Euros to Pounds Sterling. This change in the reporting currency of the Company was made to reflect the fact that the Company no longer has Euro based operations, assets or significant transactions denominated in Euros. In accordance with accounting standards, the comparative financial information for the year ended 31 March 2017 as previously reported in Euros, has been restated into Pounds Sterling using the procedures outlined in note 2.13 to the financial statements.
Adams reported a profit after tax of GBP180,000 for the year ended 31 March 2018 compared to a profit of GBP77,000 in the prior year. The increase in profitability is principally due to higher reported gains on the valuation of investments.
During the year, the Company spent GBP1.59 million on the purchase of additional investments and realised proceeds of GBP0.73 million from investment disposals. The carrying value of investments at 31 March 2018 was GBP2.08 million, represented by 3 listed and 3 un-listed investment holdings, versus GBP0.94 million at 31 March 2017, represented by 4 listed and 1 un-listed investment holdings.
Net assets increased to GBP2.11 million (equivalent to 2.55 pence per share) at the 31 March 2018 balance sheet date, compared with GBP0.95 million (equivalent to 2.29 pence per share) at the previous year end. The increase in net assets reflects net proceeds of GBP0.98 million received from new share subscriptions, together with the profit of GBP0.18 million reported for the year.
Cash and cash equivalent balances were GBP52,000 at 31 March 2018 compared to cash balances of GBP35,000 at 31 March 2017.
Underwritten open offer and majority shareholder controlled undertaking
In order to provide the Company with additional resources with which to fund its investment strategy, the Company raised GBP0.98 million (after expenses) in June 2017 pursuant to an underwritten open offer of 41,276,616 ordinary shares at 2.5p per share. Under the open offer, existing shareholders had an opportunity to subscribe for new shares at the 2.5p issue price by taking up their respective open offer entitlements which were calculated on a pro rata basis to their holding in the existing shares.
The open offer was fully underwritten by the Company's largest shareholder, Richard Griffiths and following the open offer, which was approved by shareholders on 28 June 2017, the number of Adams ordinary shares in issue increased to 82,553,232 and consequent to the subscription and underwriting shares issued to Richard Griffiths, his holding increased to 63.8 per cent of the Company's issued share capital. As a result, Adams became a controlled undertaking of Richard Griffiths who will, if he so wishes, be able to further increase his interests in Adams shares without making a mandatory offer to the remaining shareholders. Subsequent to the open offer, Richard Griffiths has purchased further Adams shares in the AIM market such that his current holding in the Company is now 77.3 per cent.
The Company, Cairn Financial Advisers LLP (who are the Company's Nominated Advisor) and Richard Griffiths entered into a relationship agreement dated 2 June 2017, which governs the relationship between the Company and Richard Griffiths following the open offer, to ensure that the Company shall be managed independently for the benefit of shareholders as a whole.
Business model and change of investing policy
On 8 September 2017, shareholders approved a proposal by the Company's directors to revise the investing policy to one which provides the Board with a broader, more flexible approach to creating shareholder value. The existing policy at that time was focused on targeting undervalued or pre-commercialisation projects and assets in the biotechnology sector, whilst also considering opportunities in the wider technology and other sectors.
Under the revised investing policy, the Board is seeking to acquire interests in special situation investment opportunities that have an element of distress, dislocation, dysfunction or other special situation attributes and that they perceive to be undervalued. The principal focus is in the small to middle-market capitalisation sectors in the UK or Europe, but the directors will also consider possible special situation opportunities anywhere in the world if they believe there is an opportunity to generate added value for shareholders.
Investment Portfolio
The listed investments currently held by the Company comprise Petrofac Limited, Eland Oil & Gas Plc and Communisis Plc. In addition, the Company holds shares and loan notes in unquoted Sherwood Holdings Limited and unquoted shares in both Abaco Capital Plc and Oxford Pharmascience Limited.
Petrofac is a multinational service provider to the oil and gas production and processing industry. The company designs, builds, operates and maintains oil and gas facilities with a focus on delivering first class project execution, cost control and effective risk management. Petrofac has a 36-year track record and has grown significantly to become a constituent of the FTSE 250 Index. The company has 31 offices and approximately 13,500 staff worldwide, comprising more than 80 nationalities.
Eland is an independent oil and gas company with the principal business objective of identifying, acquiring and developing interests in oil and gas assets in West Africa, focused initially on Nigeria including the prolific Niger Delta.
Communisis is a leading provider of outsourced digital asset management and personalised customer communication services.
Abaco Capital (formerly Oxford Pharmascience Plc) underwent a demerger of its Oxford Pharmascience Limited business on 21 December 2017 and subsequently cancelled its AIM listing on 9 May 2018. The company is now in the process of undertaking a members' voluntary liquidation and a distribution of funds to shareholders. The total amount expected to be available to distribute to shareholders is circa GBP19.0 million, on which basis Adams would receive approximately GBP30,000, and the distribution is expected to occur in the period around September to November 2018.
Oxford Pharmascience (as demerged from Abaco Capital) is a drug development company that re-develops approved drugs to make them better, safer and easier to take and it has a current focus to develop improved formulations of non-steroidal anti-inflammatory drugs (NSAIDs) and statins.
Source Bioscience is an international provider of state of the art laboratory services and products and has an expertise in clinical diagnostics, genomics, proteomics, drug discovery & development research and analytical testing services.
Corporate action proposals
Following the change in the presentational currency of Adams from Euros to Pounds Sterling during the year, it is proposed that a redenomination of the Company's share capital from Euros into Pounds Sterling is also undertaken, with the par value of the ordinary shares converting from EUR0.01 to GBP0.01, and that the AIM quotation of its ordinary shares is also subsequently changed from Euros to Pounds Sterling.
In addition, it is proposed that part of the Company's share premium be applied to eliminate the foreign currency translation reserve and that the balance of the share premium be reclassified as distributable reserves and that the Directors are authorised to purchase the Company's own ordinary shares in the open market subject to certain conditions and limited to a maximum of 14.99 per cent of the issued share capital of the Company. The Directors believe that the ability of the Company to purchase its own shares offers an important mechanism for managing capital efficiently. In particular, the Directors may wish to take advantage of circumstances where a purchase of its own shares would represent good use of the Company's available cash resources and increase net asset value per share and shareholder value.
The full detail of these corporate action proposals is included in the Notice of Annual General Meeting for the AGM which is to be held at IOMA House, Hope Street, Douglas, Isle of Man, IM1 1AP on 10 August 2018 at 11a.m.
Outlook
Global economic growth was stronger than expected in 2017, with a recovery in investment, manufacturing, and trade becoming visible. More moderate economic growth is forecast for 2018 as central banks gradually remove their post crisis fiscal accommodation. However, these positive growth trends must be tempered by the increasing threat of a decrease in liberalised global trade and the potential for the escalation of political tensions between advanced trading nations. Despite these macro considerations the Adams directors are confident in the underlying fundamentals, technologies and growth potential of the companies within our investment portfolio.
The Board continues to seek attractive investment opportunities coupled with a focus on financial discipline as the strategy to best navigate challenging markets and the uncertain global climate. We remain committed to delivering additional value for our shareholders going forward.
Michael Bretherton
Chairman
26 June 2018
Statement of Income
Year ended Year ended 31 March 2018 31 March 2017 GBP'000 GBP'000 ----------------------------------------------- --------------- ---------------- Dividend income 45 15 Gain on investments 280 204 ------------------------------------------------ --------------- ---------------- Investment return 325 219 Expenses Administrative expenses (155) (147) ------------------------------------------------ --------------- ---------------- Operating profit 170 72 Interest income 10 5 ------------------------------------------------ --------------- ---------------- Profit on ordinary activities before taxation 180 77 Tax on profit on ordinary activities - - ----------------------------------------------- --------------- ---------------- Profit for the year 180 77 ------------------------------------------------ --------------- ---------------- Basic and diluted profit per share 0.25p 0.18p ------------------------------------------------ --------------- ----------------
Statement of Comprehensive Income
Year ended Year ended 31 March 2018 31 March 2017 GBP'000 GBP'000 -------------------------------------------------------------- --------------- ---------------- Profit for the year 180 77 --------------------------------------------------------------- --------------- ---------------- Other comprehensive expense Exchange differences arising on change in reporting currency - (2) --------------------------------------------------------------- --------------- ---------------- Total comprehensive gain for the year 180 75 --------------------------------------------------------------- --------------- ----------------
Statement of Financial Position at 31 March 2018
31 March 2018 31 March 2017 31 March 2016 GBP'000 GBP'000 GBP'000 ------------------------------ -------------------- ---------------- ---------------- Assets Non-current assets Investments 2,076 935 690 ------------------------------------- -------------- ---------------- ---------------- Current assets Prepayments 2 2 2 Cash and cash equivalents 52 35 204 ------------------------------------- -------------- ---------------- ---------------- Current assets 54 37 206 ------------------------------------- -------------- ---------------- ---------------- Total assets 2,130 972 896 ------------------------------------- -------------- ---------------- ---------------- Liabilities Current liabilities Trade and other payables (21) (26) (25) ------------------------------------- -------------- ---------------- ---------------- Total liabilities (21) (26) (25) ------------------------------------- -------------- ---------------- ---------------- Net current assets 33 11 181 ------------------------------------- -------------- ---------------- ---------------- Net assets 2,109 946 871 ------------------------------------- -------------- ---------------- ---------------- Equity ------------------------------ ---- -------------- ---------------- ---------------- Called up share capital 1,001 636 636 Share premium 1,401 783 783 Foreign currency translation reserve (244) (244) (242) Accumulated losses (49) (229) (306) ------------------------------------- -------------- ---------------- ---------------- Total shareholder equity 2,109 946 871 ------------------------------------- -------------- ---------------- ----------------
Statement of Changes in Equity as at 31 March 2018
Share Foreign currency translation Accumulated Share Capital Premium reserve Losses Total GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 At 1 April 2016 636 783 (242) (306) 871 Changes in equity Total comprehensive gain - - (2) 77 75 --------------------------- -------------- --------- ------------------------------------ ------------ -------- At 31 March 2017 636 783 (244) (229) 946 --------------------------- -------------- --------- ------------------------------------ ------------ -------- Changes in equity Issue of shares 365 618 - - 983 Total comprehensive gain - - - 180 180 --------------------------- -------------- --------- ------------------------------------ ------------ -------- At 31 March 2018 1,001 1,401 (244) (49) 2,109 --------------------------- -------------- --------- ------------------------------------ ------------ --------
Statement of Cash Flows for the year ended 31 March 2018
Year ended Year ended 31 March 2017 31 March 2018 *Restated GBP'000 GBP'000 Profit for the year 180 77 Unrealised gain on revaluation of portfolio investments (237) (188) Realised gain on disposal of portfolio investments (43) (16) Decrease in prepaid expenses - 1 Decrease in trade and other payables (5) (2) ---------------------------------------------- ----------- -------------- Net cash outflow from operating activities (105) (128) ---------------------------------------------- ----------- -------------- Cash flows from investing activities Purchase of portfolio investments (1,591) (191) Proceeds from sales of investments 730 150 ---------------------------------------------- ----------- -------------- Net cash used in investing activities (861) (41) ---------------------------------------------- ----------- -------------- Cash flows from financing activities Issue of ordinary share capital 983 - Net cash generated from financing - activities 983 -------------------------------------------- ----------- -------------- Net increase / (decrease) in cash and cash equivalents 17 (169) Cash and cash equivalents at beginning of year 35 204 ---------------------------------------------- ----------- -------------- Cash and cash equivalents at end of year 52 35 ---------------------------------------------- ----------- --------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
FR FKPDDABKDFAB
(END) Dow Jones Newswires
June 26, 2018 02:00 ET (06:00 GMT)
1 Year Adams Chart |
1 Month Adams Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions